Metrorrhagia after intravitreal injection of bevacizumab.
Rodrigues
Eduardo B
EB
Shiroma
Helio
H
Meyer
Carsten H
CH
Maia
Maurício
M
Farah
Michel E
ME
D000328:Adult; D020533:Angiogenesis Inhibitors / Q000008:administration & dosage* / Q000009:adverse effects*; D000911:Antibodies, Monoclonal / Q000008:administration & dosage* / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D005260:Female; D006801:Humans; D007267:Injections; D008796:Metrorrhagia / Q000139:chemically induced*; D014822:Vitreous Body
D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab